ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes

Chen, Li; Sun, Hao; Zhao, Ruihu; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhang, Lele; Xue, Yingwei; Li, Xingrui*; Song, Hongjiang*华中科技大学; 哈尔滨医科大学
Frontiers in Pharmacology2022-3-4DOI: 10.3389/fphar.2022.836958
16被引9阅读
引用收藏
分享

摘要

Objective: The controlling nutritional status (CONUT), based on total lymphocyte count (TL), total cholesterol level (T-CHOL), and serum albumin (ALB), can provide a useful immunological prognostic biomarker for cancer patients. The present study aims to investigate the correlation between CONUT and prognosis in gastric cancer patients receiving immune checkpoint inhibitor (ICI) treatment.Methods: We retrospectively enrolled 146 patients with gastric cancer treated with ICIs (PD-1/PD-L1 inhibitors) from August 2016 to December 2020. The clinicopathologic characteristics were analyzed by Chi-square test or Fisher's exact test. The Kaplan-Meier and log-rank test were used to calculate and compare progression-free survival (PFS) and overall survival (OS). The prognostic and predictive factors of PFS and OS were identified by univariate and multivariate analyses. A nomogram was developed to estimate 1-, 3-, and 5-year PFS and OS probability.Results: Through the CONUT score, there were 75 (51.37%) patients in the low CONUT group and 71 (48.63%) patients in the high CONUT group. There was a correlation between the CONUT score and age (p = 0.005), pathology (p = 0.043), ALB (p = 0.020), PALB (p = 0.032), and Hb (p = 0.001). The CA724, TNM stage, and treatment (ICIs vs. chemotherapy) were the independent prognostic factors for PFS and OS by multivariate analyses. Patients with high CONUT score had poorer PFS and OS (chi(2) = 3.238, p = 0.072, and chi(2) = 4.298, p = 0.038). In the subgroup analysis, the patients with high CONUT score were associated with shorter PFS and OS with ICIs or chemotherapy. With the PD-1/PD-L1 positive expression, the patients with high CONUT score had shorter PFS and OS than those with low CONUT score. Furthermore, the patients with high CA724 value were associated with shorter PFS and OS. The toxicity assessment in ICIs or chemotherapy was significantly associated with anemia. The nomograms were constructed to predict the probability of 1-, 3-, and 5-year PFS, and 1-, 3-, and 5-year OS with C-indices of 0.749 and 0.769, respectively.Conclusion: The CONUT, as a novel immuno-nutritional biomarker, may be useful in identifying gastric cancer patients who are unlikely to benefit from ICI treatment.

学科与关键词

关键词
gastric cancercontrolling nutritional statusimmune checkpoint inhibitorsPD-1PD-L1
相关
加载中…
  • Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes (vol 13, 836958, 2022)
    Chen, Li; Sun, Hao; Zhao, Ruihu; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhang, Lele; Xue, Yingwei; Song, Hongjiang*; Li, Xingrui*Frontiers in Pharmacology, 2022, 13: 1079635.
  • Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors
    Sun, Hao; Chen, Li; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhao, Ruihu; Xue, Yingwei; Song, Hongjiang*Frontiers in Nutrition, 2022, 9: 1038118.被引 9
  • Prognostic Effect of the Controlling Nutritional Status Score in Patients With Esophageal Cancer Treated With Immune Checkpoint Inhibitor
    Chang, Lele; Cheng, Qian; Ma, Yue; Wu, Chunlong; Zhang, Xuemei; Ma, Qian; He, Lei; Li, Qingwei; Tao, Ji*Journal of Immunotherapy, 2022, 45(9): 415-422.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-03-04
卷期
第 13 卷
页码
836958
DOI
10.3389/fphar.2022.836958
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Department of Education of Heilongjiang Province [12541458]; Clinical Research Foundation of Wu Jieping Medical Foundation [320.6750.13105, 320.6750.18278]

作者

  • C

    Chen, Li (第一作者)

    huazhong univ sci & technol · harbin med univ

  • S

    Sun, Hao

    harbin med univ

查看全部 10 位作者收起作者
  • Z

    Zhao, Ruihu

    harbin med univ

  • H

    Huang, Rong

    harbin med univ

  • P

    Pan, Hongming

    harbin med univ

  • Z

    Zuo, Yanjiao

    harbin med univ

  • Z

    Zhang, Lele

    harbin med univ

  • X

    Xue, Yingwei

    harbin med univ

  • L

    Li, Xingrui (通讯)

    huazhong univ sci & technol

  • S

    Song, Hongjiang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417